Alignment Healthcare Inc (ALHC) Institutional Buying & Selling Tracker (Q2 2026)

ALHC ranks #1910 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

331 institutions disclose a position in ALHC, but none treat it as a major bet — even Broad Bay Capital Management, LP, its most concentrated holder, allocates just 4.2% of its own portfolio to it.

Blue Trust, Inc. has trimmed its ALHC position for two straight quarters, cutting it by $480.2K while still holding $117.8K.

ALHC is up 1.6% today, and institutions have been net buyers of $968.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

ALHC posted net income of $40.7M over the trailing twelve months, and currently trades at a P/E of 40.3.

• Profitable — net income of $40.7M over the trailing twelve months
• Revenue grew 37.2% year over year
• Net income improved year over year, from -$51.0M to $40.7M
• Generated $139.9M in positive operating cash flow
• Current ratio of 1.71x — enough short-term assets to cover short-term liabilities
• Liabilities run 4.94x equity — a highly leveraged balance sheet worth noting